Peter Geisler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Peter Geisler has a total of 303 co-authors. Here are the top co-authors by number of shared publications:
Göran Hajak
Department of Psychiatry and Psychotherapy, Center of Sleep Medicine, University of Regensburg, Regensburg, Germany
13 shared publications- Christoph Pieh
University for Continuing Education Krems
7 shared publications - Yves Dauvilliers
Institute of Neurosciences of Montpellier (INM), University of Montpellier, INSERM , Montpellier
7 shared publications - Birgit Högl
Neurology Department, Sleep Disorders Clinic Innsbruck Medical University Innsbruck Austria
6 shared publications Geert Mayer
Hephata-Clinic for Neurology, Schwalmstadt-Treysa, Germany
6 shared publicationsJürgen Zulley
Department of Psychiatry and Psychotherapy, Center of Sleep Medicine, University of Regensburg, Universitätsstrasse 84, 93053, Regensburg, Germany
6 shared publications
Latest Publications
- Open Access
- 18 March 2025
- Published by Wiley in Journal of Sleep Research
- Vol. 34 (6) , e70039
Sleep and Aging. A Polysomnographic Follow‐Up Study, Some 40 Years Later
The aim of the present study was to explore age‐related sleep alterations in normal subjects whose sleep had been recorded for the first time 40.4 ± 4.8 years ago. For the follow‐up polysomnography (3 nights) 15 participants (5 female, 10 male, age 56–74 years) were recruited. Recording conditions and sleep scoring were adapted to the previous study. In all older participants, the amount of slow‐wave sleep and REM sleep was decreased, while stage 1 and wakefulness were increased. There was no significant change in stage 2 or in any of the additional REM sleep parameters (REM density, latency, number and duration of REM cycles). Sleep stage transition analysis showed a markedly reduced stability of SWS from young to older age. While none of the single sleep parameters showed intra‐individual stability with age, a pattern analysis, which combined seven sleep parameters (sleep stages, total sleep time and REM density), showed that the concordance rate of the combined sleep parameters correlated significantly with the age at follow‐up. The results of this longitudinal study over a period of about 40 years are largely consistent with those of cross‐sectional studies. While the lack of significant correlation of the individual sleep parameters between the younger and older age groups did not allow for the identification of any of them as trait markers, the result of the pattern analysis, which combined a set of sleep parameters, indicates that the stability of the sleep structure decreases significantly in the age range between the late 50s and early 70s.
- 18 March 2025
- Published by Wiley in Journal of Sleep Research
- Vol. 34 (6) , e70039
Open AccessSleep and Aging. A Polysomnographic Follow‐Up Study, Some 40 Years Later
The aim of the present study was to explore age‐related sleep alterations in normal subjects whose sleep had been recorded for the first time 40.4 ± 4.8 years ago. For the follow‐up polysomnography (3 nights) 15 participants (5 female, 10 male, age 56–74 years) were recruited. Recording conditions and sleep scoring were adapted to the previous study. In all older participants, the amount of slow‐wave sleep and REM sleep was decreased, while stage 1 and wakefulness were increased. There was no significant change in stage 2 or in any of the additional REM sleep parameters (REM density, latency, number and duration of REM cycles). Sleep stage transition analysis showed a markedly reduced stability of SWS from young to older age. While none of the single sleep parameters showed intra‐individual stability with age, a pattern analysis, which combined seven sleep parameters (sleep stages, total sleep time and REM density), showed that the concordance rate of the combined sleep parameters correlated significantly with the age at follow‐up. The results of this longitudinal study over a period of about 40 years are largely consistent with those of cross‐sectional studies. While the lack of significant correlation of the individual sleep parameters between the younger and older age groups did not allow for the identification of any of them as trait markers, the result of the pattern analysis, which combined a set of sleep parameters, indicates that the stability of the sleep structure decreases significantly in the age range between the late 50s and early 70s.
- Open Access
- 7 February 2025
- Published by Elsevier in Sleep Medicine
- Vol. 129, 20-30
Interim analysis of a post-authorization safety study of pitolisant in treating narcolepsy: A real-world European study
- 7 February 2025
- Published by Elsevier in Sleep Medicine
- Vol. 129, 20-30
Open AccessInterim analysis of a post-authorization safety study of pitolisant in treating narcolepsy: A real-world European study
- Open Access
- 13 March 2024
- Published by Springer Nature in Somnologie
- Vol. 28 (2) , 149-155
Daytime sleepiness in patients with untreated restless legs syndrome
Background: Restless legs syndrome (RLS), a disorder characterized by an urge to move one’s legs during sleep or rest, leads to impaired sleep quality. Many patients with RLS report increased daytime sleepiness, but this has seldom been the focus of clinical research. The current study empirically investigated the prevalence and severity of daytime sleepiness in RLS. Methods: This prospective study included 29 newly diagnosed treatment-naïve patients with RLS and 31 healthy controls and assessed standardized subjective (tiredness symptom scale [TSS], Stanford Sleepiness Scale [SSS], Epworth Sleepiness Scale [ESS]), cognitive (psychomotor vigilance task [PVT], Mackworth Clock Test [MCT]), and physiological measures (pupillary unrest index [PUI]). RLS symptom severity was assessed, and the effects of RLS on general health aspects and subjective sleep quality (Pittsburgh Sleep Quality Index) were compared to control data. Results: Patients had moderate to severe RLS with significant negative effects on general health, quality of life, and sleep quality. Patients with RLS showed more subjective daytime sleepiness (ESS) and current sleepiness (TSS, SSS) than controls. The objective performance of patients in sustained attention tasks (P VT, MCT) was significantly worse than that of controls. Additionally, patients showed higher PUI scores. Conclusion: In the present study, RLS was associated with markedly impaired subjective sleep quality and with subjectively and objectively increased daytime sleepiness. Since daytime sleepiness can be a major factor leading to compromised quality of life, assessing and treating sleepiness should be incorporated into standard diagnostics and treatment.
- 13 March 2024
- Published by Springer Nature in Somnologie
- Vol. 28 (2) , 149-155
Open AccessDaytime sleepiness in patients with untreated restless legs syndrome
Background: Restless legs syndrome (RLS), a disorder characterized by an urge to move one’s legs during sleep or rest, leads to impaired sleep quality. Many patients with RLS report increased daytime sleepiness, but this has seldom been the focus of clinical research. The current study empirically investigated the prevalence and severity of daytime sleepiness in RLS. Methods: This prospective study included 29 newly diagnosed treatment-naïve patients with RLS and 31 healthy controls and assessed standardized subjective (tiredness symptom scale [TSS], Stanford Sleepiness Scale [SSS], Epworth Sleepiness Scale [ESS]), cognitive (psychomotor vigilance task [PVT], Mackworth Clock Test [MCT]), and physiological measures (pupillary unrest index [PUI]). RLS symptom severity was assessed, and the effects of RLS on general health aspects and subjective sleep quality (Pittsburgh Sleep Quality Index) were compared to control data. Results: Patients had moderate to severe RLS with significant negative effects on general health, quality of life, and sleep quality. Patients with RLS showed more subjective daytime sleepiness (ESS) and current sleepiness (TSS, SSS) than controls. The objective performance of patients in sustained attention tasks (P VT, MCT) was significantly worse than that of controls. Additionally, patients showed higher PUI scores. Conclusion: In the present study, RLS was associated with markedly impaired subjective sleep quality and with subjectively and objectively increased daytime sleepiness. Since daytime sleepiness can be a major factor leading to compromised quality of life, assessing and treating sleepiness should be incorporated into standard diagnostics and treatment.
- 9 March 2024
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 47 (5)
The wake intrusion index: a new approach to arousals, a new perspective on insomnia?
Peter Geisler; The Wake Intrusion Index: A new approach to arousals, a new perspective on insomnia?, Sleep, , zsae069, https://doi.org/10.1093/sleep/zsae069
- 9 March 2024
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 47 (5)
The wake intrusion index: a new approach to arousals, a new perspective on insomnia?
Peter Geisler; The Wake Intrusion Index: A new approach to arousals, a new perspective on insomnia?, Sleep, , zsae069, https://doi.org/10.1093/sleep/zsae069
- 26 August 2021
- Published by Springer Nature in Somnologie
- Vol. 25 (3) , 235-246
Insomnie – diagnostische Ansätze und Verfahren
- 26 August 2021
- Published by Springer Nature in Somnologie
- Vol. 25 (3) , 235-246
Insomnie – diagnostische Ansätze und Verfahren
- 1 September 2019
- Published by Elsevier in Behavior Therapy
- Vol. 50 (5) , 994-1001
Changes in Subjective-Objective Sleep Discrepancy Following Inpatient Cognitive Behavior Therapy for Insomnia
- 1 September 2019
- Published by Elsevier in Behavior Therapy
- Vol. 50 (5) , 994-1001
Changes in Subjective-Objective Sleep Discrepancy Following Inpatient Cognitive Behavior Therapy for Insomnia
- Open Access
- 1 March 2016
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 39 (3) , 581-587
Narcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity
Study Objectives:. Narcolepsy with cataplexy is tightly associated with the HLA class II allele DQB1*06:02. Evidence indicates a complex contribution o
- 1 March 2016
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 39 (3) , 581-587
Open AccessNarcolepsy-Associated HLA Class I Alleles Implicate Cell-Mediated Cytotoxicity
Study Objectives:. Narcolepsy with cataplexy is tightly associated with the HLA class II allele DQB1*06:02. Evidence indicates a complex contribution o
- 26 January 2016
- Published by Wiley in Journal of Sleep Research
- Vol. 25 (3) , 356-364
The European Narcolepsy Network (EU‐NN) database
Summary: Narcolepsy with cataplexy is a rare disease with an estimated prevalence of 0.02% in European populations. Narcolepsy shares many features of rare disorders, in particular the lack of awareness of the disease with serious consequences for healthcare supply. Similar to other rare diseases, only a few European countries have registered narcolepsy cases in databases of the International Classification of Diseases or in registries of the European health authorities. A promising approach to identify disease‐specific adverse health effects and needs in healthcare delivery in the field of rare diseases is to establish a distributed expert network. A first and important step is to create a database that allows collection, storage and dissemination of data on narcolepsy in a comprehensive and systematic way. Here, the first prospective web‐based European narcolepsy database hosted by the European Narcolepsy Network is introduced. The database structure, standardization of data acquisition and quality control procedures are described, and an overview provided of the first 1079 patients from 18 European specialized centres. Due to its standardization this continuously increasing data pool is most promising to provide a better insight into many unsolved aspects of narcolepsy and related disorders, including clear phenotype characterization of subtypes of narcolepsy, more precise epidemiological data and knowledge on the natural history of narcolepsy, expectations about treatment effects, identification of post‐marketing medication side‐effects, and will contribute to improve clinical trial designs and provide facilities to further develop phase III trials.
- 26 January 2016
- Published by Wiley in Journal of Sleep Research
- Vol. 25 (3) , 356-364
The European Narcolepsy Network (EU‐NN) database
Summary: Narcolepsy with cataplexy is a rare disease with an estimated prevalence of 0.02% in European populations. Narcolepsy shares many features of rare disorders, in particular the lack of awareness of the disease with serious consequences for healthcare supply. Similar to other rare diseases, only a few European countries have registered narcolepsy cases in databases of the International Classification of Diseases or in registries of the European health authorities. A promising approach to identify disease‐specific adverse health effects and needs in healthcare delivery in the field of rare diseases is to establish a distributed expert network. A first and important step is to create a database that allows collection, storage and dissemination of data on narcolepsy in a comprehensive and systematic way. Here, the first prospective web‐based European narcolepsy database hosted by the European Narcolepsy Network is introduced. The database structure, standardization of data acquisition and quality control procedures are described, and an overview provided of the first 1079 patients from 18 European specialized centres. Due to its standardization this continuously increasing data pool is most promising to provide a better insight into many unsolved aspects of narcolepsy and related disorders, including clear phenotype characterization of subtypes of narcolepsy, more precise epidemiological data and knowledge on the natural history of narcolepsy, expectations about treatment effects, identification of post‐marketing medication side‐effects, and will contribute to improve clinical trial designs and provide facilities to further develop phase III trials.
- 1 November 2015
- Published by Elsevier in Sleep Medicine
- Vol. 16 (11) , 1313-1320
The effect of sleep deprivation on pain perception in healthy subjects: a meta-analysis
- 1 November 2015
- Published by Elsevier in Sleep Medicine
- Vol. 16 (11) , 1313-1320
The effect of sleep deprivation on pain perception in healthy subjects: a meta-analysis